United Therapeutics: Jefferies raises target price
(CercleFinance.com) - An analyst at Jefferies said on Tuesday that he is raising his target price for the United Therapeutics stock from 127 dollars to 135 dollars.
He thereby confirms his "Buy" rating on the share.
The broker says that it has increased its forecasts regarding the potential of Tyvaso in new indications, after an interiew with a specialist in cardiology and pneumology.
The share is up about 2% in early trading on Tuesday at 121.7 dollars.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.